AdvancedcardiovascularPhysiology
The Renin-Angiotensin-Aldosterone System (RAAS)
Overview
The renin-angiotensin-aldosterone system is the body's main hormonal defense of blood pressure and volume over minutes to days. Falling renal perfusion triggers renin release, which starts a cascade producing angiotensin II - a potent vasoconstrictor that also drives aldosterone secretion, causing the kidneys to retain sodium and water. It is one of the most clinically targeted pathways in medicine.
Learning objectives
- List the RAAS cascade steps from renin to aldosterone effects
- Name the three triggers of renin release
- Explain angiotensin II's vascular and adrenal actions
- Describe how aldosterone raises blood volume
- Explain why ACE inhibitors lower blood pressure
Process steps
Three signals trigger renin release from juxtaglomerular cells: low blood pressure in the afferent arteriole (sensed directly), low sodium delivery to the macula densa, and sympathetic stimulation via beta-1 receptors during stress or volume loss.
Renin, an enzyme released into the blood, cleaves angiotensinogen (made by the liver) into angiotensin I, a relatively inactive ten-amino-acid peptide.
Angiotensin-converting enzyme, abundant in lung capillaries, removes two amino acids from angiotensin I to form angiotensin II, the cascade's main effector - an eight-amino-acid peptide with a half-life of only minutes.
Angiotensin II binds AT1 receptors on arteriolar smooth muscle, causing powerful vasoconstriction that raises total peripheral resistance within minutes. It also constricts the efferent arteriole of the glomerulus, preserving filtration pressure when perfusion falls.
Angiotensin II stimulates the adrenal cortex to release aldosterone, which acts on the kidney's collecting ducts to reabsorb sodium (and with it water) while secreting potassium. Blood volume expands over hours to days, raising cardiac output and pressure.
Angiotensin II also triggers ADH release and thirst (adding water), enhances sympathetic activity, and promotes tissue remodeling. Together, the fast vasoconstriction and slow volume expansion restore perfusion pressure.
Key variables
| Variable | Unit | Typical range | Role |
|---|---|---|---|
| Angiotensin II half-life | minutes | About 1-2 | Short-lived effector; the system tracks current conditions, not history |
| Aldosterone effect onset | hours | Several hours to peak | Requires new protein synthesis in kidney tubule cells |
| Renin triggers | stimuli | Low pressure, low NaCl at macula densa, sympathetic beta-1 | Three independent sensors of volume/pressure status |
| Sodium retained per aldosterone surge | mmol/day | Variable; up to hundreds | Each retained sodium osmotically holds water, expanding volume |
| AT1 receptor | receptor type | G-protein coupled | Mediates vasoconstriction, aldosterone release, and remodeling |
Feedback loops
Volume restoration negative feedback
- Blood volume and pressure fall
- Renin release rises
- Angiotensin II and aldosterone increase
- Vasoconstriction plus salt/water retention restore volume and pressure
Macula densa feedback negative feedback
- Low tubular sodium reaches the macula densa
- Renin secretion increases
- Angiotensin II constricts the efferent arteriole
- Glomerular filtration and sodium delivery recover
The cascade step by step
Angiotensinogen (liver) -> renin (kidney) -> angiotensin I -> ACE (lungs) -> angiotensin II -> AT1 receptors -> vasoconstriction + aldosterone (adrenal) -> sodium/water retention. Each arrow is a potential drug target, which is why this pathway dominates cardiovascular pharmacology.
Renin -> angiotensin I -> (ACE) -> angiotensin II -> aldosterone. Learn it as a chain: enzyme, peptide, enzyme, effector, hormone.
The three renin triggers
Juxtaglomerular cells release renin when they sense low stretch in the afferent arteriole (low pressure), when the macula densa reports low tubular sodium chloride (low filtration), and when sympathetic beta-1 receptors are stimulated. Together they make renin release a faithful reporter of effective circulating volume.
The juxtaglomerular apparatus - granular cells plus macula densa - is where the kidney tastes its own perfusion and decides whether to call for help.
Angiotensin II: the rapid effector
Angiotensin II is among the most potent vasoconstrictors known, raising total peripheral resistance within minutes. Its selective constriction of the efferent arteriole is physiologically elegant: it maintains glomerular filtration pressure even as overall renal blood flow falls, protecting filtration during volume loss.
ACE inhibitors and ARBs are prescription drugs. This lesson explains the pathway they target, not their use.
Aldosterone: the slow volume builder
Aldosterone inserts sodium channels and sodium-potassium pumps into collecting-duct cells, reclaiming sodium from the urine. Water follows osmotically, expanding blood volume over hours to days. The trade-off is potassium loss, which is why RAAS activation tends to lower plasma potassium.
Clinical relevance
Because RAAS raises pressure through both resistance and volume, blocking it at multiple points - renin, ACE, AT1 receptors, aldosterone receptors - is a cornerstone of hypertension and heart failure therapy. Chronic overactivation also drives cardiac and vascular remodeling, linking the system to long-term cardiovascular disease.
Key points
- Falling renal perfusion triggers renin release via three sensors.
- Renin -> angiotensin I -> ACE -> angiotensin II -> aldosterone.
- Angiotensin II constricts vessels rapidly; aldosterone expands volume slowly.
- The system defends pressure through both resistance and volume.
- It is a major drug target in hypertension and heart failure.
Common misconceptions
✓ Truth: Only the vasoconstrictor arm is fast (minutes). Aldosterone's volume effects take hours to days because they require new transport proteins in kidney cells.
✓ Truth: It also stimulates aldosterone and ADH release, increases thirst and sympathetic activity, and promotes long-term tissue remodeling - a full defense program, not just constriction.
✓ Truth: Renin release is a normal, essential response to volume loss, dehydration, or blood loss. Problems arise from chronic, inappropriate activation, not from the system working as designed.
Practice questions
Q1. Renin is released by the kidneys in response to all of the following EXCEPT:
- Low afferent arteriole pressure
- Low NaCl at the macula densa
- Sympathetic beta-1 stimulation
- High atrial stretch
High atrial stretch triggers natriuretic peptides, which oppose RAAS. The three renin triggers are low pressure, low macula densa NaCl, and sympathetic stimulation.
Q2. Angiotensin-converting enzyme (ACE) is most abundant in the:
- Kidney tubules
- Lung capillaries
- Liver sinusoids
- Adrenal cortex
ACE is highly expressed on lung capillary endothelium, so angiotensin II is generated as blood passes through the pulmonary circulation.
Q3. Aldosterone raises blood pressure primarily by:
- Directly constricting arterioles
- Promoting renal sodium and water retention
- Increasing heart rate
- Dilating veins
Aldosterone inserts sodium transporters in the collecting duct; reabsorbed sodium holds water osmotically, expanding blood volume.
Q4. Angiotensin II preserves glomerular filtration during low perfusion by:
- Dilating the afferent arteriole
- Constricting the efferent arteriole
- Increasing heart rate
- Blocking ADH
Efferent constriction raises glomerular capillary pressure, maintaining filtration even as renal blood flow falls.
Click a question to reveal the answer and explanation.
Frequently asked questions
What triggers renin release?
Low pressure sensed by juxtaglomerular cells, low sodium chloride delivery sensed by the macula densa, and sympathetic beta-1 stimulation. All three signal that effective circulating volume is threatened.
What is the difference between angiotensin I and II?
Angiotensin I is a weak precursor made by renin's action on angiotensinogen. ACE converts it to angiotensin II, the potent effector that constricts vessels and triggers aldosterone release.
How does aldosterone raise blood pressure?
It makes kidney collecting ducts reabsorb sodium; water follows osmotically, expanding blood volume. Greater volume raises venous return, cardiac output, and ultimately arterial pressure.
Why do ACE inhibitors lower blood pressure?
They block the conversion of angiotensin I to angiotensin II, reducing vasoconstriction and aldosterone-driven volume expansion. They also slow bradykinin breakdown, adding vasodilation.